Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN

Armistice Capital, LLC reported a 5.06% stake in Supernus Pharmaceuticals, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Armistice Capital, LLC reported a 5.06% stake in Supernus Pharmaceuticals, Inc., 2,836,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
5.06%
Shares
2,836,000
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC5.06%2,836,000
Steven Boyd5.06%2,836,000

Source

View original at SEC

Related